HIMS Hims & Hers Health, Inc.

HIMS Hims & Hers Health, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Market read

Scan convergence 3 scans as of 2026-08-17 1 bear 2 neutral converging

POC $27.70 · VWAP $33.24 · -13.9% vs 12m avg buyer

downtrend vol: normalgaps: stablechurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

HIMS Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist HIMS belongs to, members best 30-day change first — HIMS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@cultural-thesis
@peptide-economy
@consumer
@insider-universe
View watchlist →
U+56.8% -1.7%1d +5.5%7d MDB+40.5% -4.7%1d +5.3%7d FSLY+40.1% -3.0%1d +4.6%7d ESTC+35.5% -3.7%1d +9.4%7d PLTR+30.3% -0.9%1d -1.5%7d MRVL+24.2% +5.5%1d +12.4%7d ZS+23.0% +0.5%1d +4.5%7d ABNB+22.8% -2.6%1d -2.9%7d SNOW+22.8% +0.4%1d -1.4%7d MSFT+22.0% -3.0%1d -5.0%7d SHOP+20.3% -3.7%1d -4.2%7d ZM+15.8% -0.4%1d -1.5%7d ASAN+14.8% -3.4%1d -4.2%7d NOW+14.0% -5.1%1d -7.6%7d DOCN+13.8% +4.1%1d +4.3%7d CRSP+13.6% +1.4%1d +1.6%7d ISRG+13.0% -1.1%1d -0.8%7d CRM+11.8% -2.7%1d -3.3%7d NVDA+10.9% -0.1%1d +3.4%7d NET+10.6% -2.8%1d -1.1%7d TWLO+10.6% -4.0%1d -8.8%7d NFLX+10.3% -2.7%1d -0.3%7d CEG+10.2% -1.5%1d +2.9%7d TMO+10.0% -0.5%1d -2.3%7d INTC+8.9% +1.0%1d +6.1%7d TSM+8.2% +1.1%1d +3.0%7d BE+8.0% +1.0%1d +10.2%7d ASML+7.9% +2.1%1d +8.6%7d UIE+6.9% +1.9%1d +2.1%7d NTLA+6.2% +1.5%1d +0.6%7d VRTX+6.2% +1.9%1d -1.6%7d SOFI+6.0% +0.1%1d +1.2%7d AVGO+5.8% -0.1%1d -7.1%7d AMZN+5.7% -0.5%1d -6.0%7d CRWD+5.3% -1.4%1d -5.0%7d PANW+4.8% -2.2%1d -2.4%7d MRNA+4.3% +1.8%1d +7.7%7d IBKR+4.2% +2.5%1d +4.1%7d UBER+3.5% -1.3%1d -3.9%7d FSLR+2.8% -3.4%1d -8.9%7d AKAM+2.3% -1.6%1d +4.6%7d AMD+2.1% -1.6%1d +7.8%7d ARM+1.6% -2.9%1d +1.4%7d LLY+0.3% +0.3%1d -3.8%7d BNTX+0.1% -1.6%1d -1.3%7d PINS-0.6% -4.1%1d -5.3%7d GOOGL-0.8% -0.6%1d -3.8%7d AFRM-2.0% -4.9%1d -1.4%7d FTNT-3.6% -2.6%1d -5.1%7d COIN-4.2% +1.4%1d +1.3%7d DDOG-4.4% -3.2%1d -5.2%7d EOSE-5.1% -2.5%1d -3.0%7d QCOM-5.6% -2.2%1d 0.0%7d ENPH-7.0% -4.5%1d -5.5%7d AAPL-8.4% -0.1%1d -0.8%7d TSLA-10.9% -0.9%1d +2.5%7d META-11.9% -3.5%1d -4.4%7d HIMS-12.9% +1.6%1d -9.9%7d RBLX-26.6% -0.8%1d +2.3%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jul 2 pass n/a Watched, not owned -18.0% complete

Desk commentary

Authored analysis and challenge notes tied to HIMS.

1

Next earnings HIMS reports in 83 days Nov 9

Last report Aug 10

Hims & Hers reported Q2 after Monday's close (Aug 10): a loss of $0.40 per share — wider than consensus — against revenue up 3.8% year over year, with revenue and guidance described as stronger than expected. Coverage also flags renewed legal scrutiny from an FTC lawsuit over data sharing and billing practices.

full note →

Against street estimates

How HIMS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 10 · projection Aug 17

Result
Aug 10 -0.05-0.37-640.0%Miss
May 11 0.03-0.40-1664.3%Miss
Feb 23 0.040.08+92.5%Beat
Nov 3 '25 0.100.06-41.0%Miss
Aug 4 '25 0.230.29 GAAP ≠ +26.3%Beat
May 5 '25 0.120.20+65.0%Beat
Feb 24 '25 0.110.11+0.7%In line
Nov 4 '24 0.050.32+533.5%Beat

Recent news

Headlines about HIMS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 7 days ago · Aug 11

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 10 Catalyst HIMS earnings
May 11 Catalyst HIMS earnings
Apr 27 Reference YOLO Playbook
Mar 20 Update Consumer
Mar 13 Update Consumer
Mar 12 Update Consumer
Mar 11 Update Consumer
Mar 10 Update Consumer
Feb 26 Update Consumer
Feb 22 Update Consumer
Feb 16 Update Consumer
Feb 11 Article Daily Actions